SCHEMBL3343073

SCHEMBL3343073

Cc1cc(Cl)c(CN2CCOC2=O)cc1N

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 20/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343069 0.82 CYP11B2 (0.39) P2RX7
SCHEMBL16335719 0.75 P2RX7 (0.49) P2RX7
SCHEMBL3347437 0.74 CYP2A13 (0.55)
SCHEMBL16335337 0.71 NPC1 (0.39) P2RX7
SCHEMBL12931886 0.69 ALDH1A1 (0.44) P2RX7
SCHEMBL20695806 0.68 KDM4E (0.44) P2RX7
SCHEMBL22771044 0.68 GRIN1 (0.39)
SCHEMBL259624 0.67 GRM2 (0.53)
SCHEMBL14002387 0.67 SMN1; SMN2 (0.55)
SCHEMBL9826977 0.67 ACHE (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 P2RX7 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.